Ferx, Inc.

Aurora, CO 80010

SBIR Award Summary

Total Number of Awards 7
Total Value of Awards $1.04MM
First Award Date 08/01/95
Most Recent Award Date 09/01/03

Key Personnel

Last Name Name Awards Contact
Allen Larry M Allen 1
Rudge Scott Raymond Rudge 1
Li Yuhua Li 2
Tapolsky Gilles H Tapolsky 3

7 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/03 - 08/31/04

DESCRIPTION (provided by applicant): The ability to deliver high doses of radiation (up to 200 Gy and higher) to a tumor without significant damage to surrounding tissue would be a significant advancement in the radiation therapy of solid tumors. FeRx proposes to complete the preclinical and clinical development of targeted radioactive micropart...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/15/03 - 07/31/04
PI: Yuhua Li

DESCRIPTION (provided by applicant): Pancreatic cancer represents the fifth most common cause of cancer related mortality in the US and is still considered to be incurable. The two chemotherapeutic agents used most commonly are 5-fluorouracil (5-FU) and gemcitabine. Several randomized clinical trials have shown that gemcitabine was slightly bett...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/03 - 03/31/04
PI: Yuhua Li

DESCRIPTION (provided by applicant): Current cancer therapy is usually systemic which results in relatively low drug concentrations at the tumor and a high rate of toxic side effects. The challenge in cancer therapy is how to deliver the therapeutic agents directly to the tumors at a high concentration and yet maintain low systemic concentration...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/02 - 08/31/03

DESCRIPTION (provided by applicant): The ability to deliver high doses of radiation (up to 200 Gy and higher) to a tumor without significant damage to surrounding tissue would be a significant advancement in the radiation therapy of solid tumors. FeRx proposes to complete the preclinical and clinical development of targeted radioactive micropart...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/01 - 02/28/02

DESCRIPTION (Applicant's Abstract): The delivery of drugs to targeted sites has been suggested to improve the efficacy of treatment while decreasing systemic side effects. Magnetically targeted carriers (MTCs) are microparticles composed of metallic iron and activated carbon capable of binding a wide variety of pharmac...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/25/00 - 08/31/01

The ability to deliver high doses of radiation to a tumor without significant damage to surrounding tissue would be a significant advancement in the radiation therapy of solid tumors. FeRx proposes to develop a convenient and safe regimen based on magnetic targeted delivery of radionuclides. Magnetic Targeted Carriers (MTCs) are 0.5 to 1.5 micro...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/95 - 12/31/95